Compound 3i

Bocsci201821 Oct, 2021News

Compound 3i is a VHL-based PROTAC targeting the TANK-binding kinase 1 (TBK1), which has been implicated in innate immune response, tumorigenesis, and development. Compound 3i is a VHL-based PROTAC targeting the TANK-binding kinase 1 (TBK1), which has been implicated in innate immune response, tumorigenesis, and development. Compound 3i is a VHL-based PROTAC targeting the TANK-binding kinase 1 (TBK1), which has been implicated in innate immune response, tumorigenesis, and development. Compound 3i is a VHL-based PROTAC targeting the TANK-binding kinase 1 (TBK1), which has been implicated in innate immune response, tumorigenesis, and development. Compound 3i is a VHL-based PROTAC targeting the TANK-binding kinase 1 (TBK1), which has been implicated in innate immune response, tumorigenesis, and development. Compound 3i is a VHL-based PROTAC targeting the TANK-binding kinase 1 (TBK1), which has been implicated in innate immune response, tumorigenesis, and development.